From January 30 to February 1, the 9th International Radio-Oncology Congress was held with the aim of advancing scientific programs in the community and supporting the expansion of cancer research. At Actero Middle East, we were honored to be one of the sponsors of this scientific event, standing alongside researchers, professors, and specialists in this field.

This congress focused on three main themes:
Oncology and Personalized Medicine – Marking a new era in cancer treatment based on genomic data
The Use of Artificial Intelligence in Oncology – Exploring AI’s impact and its role in transforming the landscape of oncology and cancer research
Ethics and Oncology – Striking a balance between innovation and ethical principles in patient care

This event provided a valuable platform for interaction among researchers and specialists, introducing new strategies, and enhancing scientific responsiveness and we at Actero Middle East remain committed to supporting scientific development and innovation in this field.

We extend our gratitude to all the professors, researchers, and colleagues who participated in this congress.
Together, we take steps toward a brighter future in cancer treatment.